On October 29, 2021, Teri Loxam notified SQZ Biotechnologies Company of her resignation as chief financial officer of the company, effective November 11, 2021, to pursue another opportunity with broader responsibilities. Following the Effective Date, Ms. Loxam will continue to provide consulting and advisory services to the Company through the filing of the Company?s Annual Report on Form 10-K for the year ended December 31, 2021, anticipated in March 2022. The Company has commenced a search for a replacement to lead the Company?s financial and investor relations activities. In the interim as of the Effective Date, the Company?s Chief Business Officer and Chief Accounting Officer will be supported by Ms. Loxam who will serve as the company?s acting chief financial officer.